• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. Sphere-9; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. Sphere-9; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH Back to Search Results
Model Number AFR-00001
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Muscle Weakness/Atrophy (1967); Embolism/Embolus (4438)
Date of Event 08/31/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that following a cardiac ablation procedure, the patient arrived in atrial fibrillation.Atrium ablation lesions were created.Transeptal access was utilized during the procedure.The patient was not on oral anticoagulation prior to procedure.Continuous irrigation was maintained on both catheter and sheath.Heparinized saline was used to flush the sheath.Imaging was not performed prior to beginning of the procedure to rule out thrombus.The patient showed loss of strength in their right hand the next day after procedure.A computerized tomography (ct) scan was performed the day after the procedure but results were clear.An magnetic resonance imaging (mri) was then performed 2 days after the procedure and showed an acute embolic event in the patient's posterior frontal lobe.No intervention was required to treat the issue.The case was completed.No further patient complications have been r eported as a result of this event.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Sphere-9
Common Device Name
PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH
Manufacturer (Section D)
MEDTRONIC, INC.
880 technology park drive
billerica MA 01821
Manufacturer (Section G)
MEDTRONIC, INC.
880 technology park drive
billerica MA 01821
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
+353(091)708096
MDR Report Key50786624
Report Number3012520654-2026-00496
Device Sequence Number9525186
Product Code QZI
UDI-Device Identifier00763000993269
UDI-Public(01)00763000993269(17)270717(10)0234023789
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
P240013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberAFR-00001
Device Catalogue NumberAFR-00001
Device Lot Number0234023789
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/02/2026
Initial Report FDA Received Date09/16/2026
Date Device Manufactured06/17/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age81 YR
Patient SexFemale
-
-